203 related articles for article (PubMed ID: 27354764)
1. Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.
Wang Z; Wang L; Xu RA; Zhan YY; Huang CK; Dai DP; Cai JP; Hu GX
Drug Des Devel Ther; 2016; 10():1909-16. PubMed ID: 27354764
[TBL] [Abstract][Full Text] [Related]
2. Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro.
Liang B; Zhan Y; Huang X; Gu E; Dai D; Cai J; Hu G
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):759-765. PubMed ID: 26542054
[TBL] [Abstract][Full Text] [Related]
3. Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitro.
Hu XX; Yuan LJ; Fang P; Mao YH; Zhan YY; Li XY; Dai DP; Cai JP; Hu GX
Drug Metab Pharmacokinet; 2016 Apr; 31(2):133-8. PubMed ID: 27016952
[TBL] [Abstract][Full Text] [Related]
4. Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro.
Cai J; Dai DP; Geng PW; Wang SH; Wang H; Zhan YY; Huang XX; Hu GX; Cai JP
Basic Clin Pharmacol Toxicol; 2016 Mar; 118(3):190-9. PubMed ID: 26310775
[TBL] [Abstract][Full Text] [Related]
5. The role of CYP2C9 genetic polymorphism in carvedilol O-desmethylation in vitro.
Pan PP; Weng QH; Zhou CJ; Wei YL; Wang L; Dai DP; Cai JP; Hu GX
Eur J Drug Metab Pharmacokinet; 2016 Feb; 41(1):79-86. PubMed ID: 25476996
[TBL] [Abstract][Full Text] [Related]
6. Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro.
Wang H; Dai DP; Sun P; Xu LP; Liang BQ; Cai JP; Hu GX
Chem Biol Interact; 2017 Feb; 264():10-15. PubMed ID: 28087463
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
Fang P; Zheng X; He J; Ge H; Tang P; Cai J; Hu G
Drug Des Devel Ther; 2017; 11():1283-1290. PubMed ID: 28461741
[TBL] [Abstract][Full Text] [Related]
8. In vitro assessment of 24 CYP2D6 allelic isoforms on the metabolism of methadone.
Su Y; Zhan YY; Wang BF; Wang SC; Dai DP; Hu GX; Lin H; Lian QQ; Cai JP
Drug Test Anal; 2017 Feb; 9(2):216-220. PubMed ID: 26968424
[TBL] [Abstract][Full Text] [Related]
9. Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol.
Takekuma Y; Takenaka T; Kiyokawa M; Yamazaki K; Okamoto H; Kitabatake A; Tsutsui H; Sugawara M
J Pharm Pharm Sci; 2006; 9(1):101-12. PubMed ID: 16849011
[TBL] [Abstract][Full Text] [Related]
10. Effect of CYP2D6 variants on venlafaxine metabolism in vitro.
Zhan YY; Liang BQ; Wang H; Wang ZH; Weng QH; Dai DP; Cai JP; Hu GX
Xenobiotica; 2016; 46(5):424-9. PubMed ID: 26406933
[TBL] [Abstract][Full Text] [Related]
11. Effects of 24 CYP2D6 Variants Found in the Chinese Population on the Metabolism of Risperidone.
Wang ZH; Zhan YY; Li YX; Yang CC; Cai J; Dai DP; Hu GX; Cai JP
Pharmacology; 2015; 96(5-6):290-5. PubMed ID: 26544071
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation.
Saito T; Gutiérrez Rico EM; Kikuchi A; Kaneko A; Kumondai M; Akai F; Saigusa D; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2018 Dec; 33(6):250-257. PubMed ID: 30366777
[TBL] [Abstract][Full Text] [Related]
13. Effect of 24 Cytochrome P450 2D6 Variants Found in the Chinese Population on Atomoxetine Metabolism in vitro.
Liang B; Zhan Y; Wang Y; Gu E; Dai D; Cai J; Hu G
Pharmacology; 2016; 97(1-2):78-83. PubMed ID: 26666748
[TBL] [Abstract][Full Text] [Related]
14. Effects of 22 CYP2D6 Genetic Variations Newly Identified in Chinese Population on Olanzapine Metabolism in vitro.
Zhou HY; Gu EM; Chen QL; Zhan YY; Wang SH; Liang BQ; Dai DP; Cai JP; Hu GX
Pharmacology; 2016; 98(3-4):124-33. PubMed ID: 27251229
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro.
Hu X; Lan T; Dai D; Xu RA; Yuan L; Zhou Q; Li Y; Cai J; Hu G
Drug Metab Dispos; 2016 Nov; 44(11):1828-1831. PubMed ID: 27538917
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity.
Muroi Y; Saito T; Takahashi M; Sakuyama K; Niinuma Y; Ito M; Tsukada C; Ohta K; Endo Y; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2014; 29(5):360-6. PubMed ID: 24647041
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of phenytoin in 36 CYP2C9 variants found in the Chinese population.
Chen LG; Wang Z; Zhu Y; Xiong JH; Sun LR; Dai DP; Cai JP; Hu GX
Chem Biol Interact; 2016 Jun; 253():93-9. PubMed ID: 27163851
[TBL] [Abstract][Full Text] [Related]
19. Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro.
Su Y; Liang BQ; Feng YL; Zhan Y; Gu E; Chen X; Dai DP; Hu GX; Cai JP
Can J Physiol Pharmacol; 2016 Aug; 94(8):895-9. PubMed ID: 27203132
[TBL] [Abstract][Full Text] [Related]
20. CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.
Giessmann T; Modess C; Hecker U; Zschiesche M; Dazert P; Kunert-Keil C; Warzok R; Engel G; Weitschies W; Cascorbi I; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2004 Mar; 75(3):213-22. PubMed ID: 15001973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
